Document Classification

Section Type: RESULTS

Text: In contrast, compared with the placebo group, atorvastatin treatment resulted in significantly lower plasma concentrations of C-reactive protein (20. 2 % ; 1. 7 %, 35. 3 %), total cholesterol (37. 2 % ; 33. 1 %, 41. 1 %), LDL cholesterol (52. 7 % ; 47. 9 %, 57. 1 %), triacylglycerols (31. 9 % ; 20. 8 %, 41. 5 %), and tumor necrosis factor alpha (TNF-alpha ; 41. 9 % ; 19. 0 %, 58. 3 %) and increased the ratio of ex vivo whole blood lipopolysaccharide-stimulated to nonstimulated TNF-alpha concentrations (109. 7 % ; 37. 9 %, 218. 9 %).